Latest news

Filter By:

Safety, efficacy and determinants ofresponse of allogeneic CD19-specific CAR-NKcells in CD19+ B cell tumors: a phase 1/2 trial

21.03.2024 – MEDIA

Defining the Rules of Biology in the Age of Genome Writing

↳ GEN Biotechnology

20.12.2023 – MEDIA

Cell and gene therapy biotech creator Replay plucks Allogene CMO Arun Balakumaran to lead clinical trials

18.05.2023 – MEDIA

Replay Bio partners with MD Anderson’s Katy Rezvani, heads to clinic with new TCR NK cell company

14.02.2023 – MEDIA

Maker of new gene therapy vector launches its second company, looking to zero in on rare skin conditions

21.11.2022 – MEDIA

Under hub-and-spoke biotech, serial founders launch new startup hoping to make gene therapies for the eye

31.10.2022 – MEDIA

KKR backs medicine start-up as private equity pushes into sector

28.07.2022 – MEDIA

Pfizer, BMS vet hits Replay with $55M seed financing, 'Big DNA' ambitions

↳ fiercebiotech.com

27.07.2022 – MEDIA

Replay Launches with $55 Million Seed to Transform Genomic Medicine with Interlinking Technology Platforms

↳ genengnews.com

25.07.2022 – MEDIA

With AAV alternative and DNA writing tech, a new hub-and-spoke startup wants to ‘democratize’ gene therapies

25.07.2022 – MEDIA

Join Replay

Help us to author the future of genomic medicine